Yale Jen
Stock Analyst at Laidlaw & Co.
(n/a)
# 3,311
Out of 4,479 analysts
14
Total ratings
10%
Success rate
-40.99%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AFMD Affimed | Maintains: Buy | $15 → $25 | $5.16 | +384.97% | 1 | Jun 13, 2024 | |
| PHGE BiomX | Initiates: Buy | $2.5 | $0.35 | +611.04% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $7.5 | $0.81 | +827.87% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $0.32 | - | 2 | Dec 22, 2023 | |
| EVFM Evofem Biosciences | Downgrades: Hold | n/a | $0.01 | - | 2 | Dec 13, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $0.95 | +956.19% | 1 | Aug 28, 2023 | |
| TCRT Alaunos Therapeutics | Downgrades: Hold | n/a | $0.63 | - | 1 | Aug 15, 2023 | |
| BLPH Bellerophon Therapeutics | Downgrades: Hold | n/a | $0.06 | - | 2 | Jun 6, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $6 | $0.20 | +2,900.00% | 1 | Sep 6, 2022 | |
| VINC Vincerx Pharma | Initiates: Buy | n/a | $0.74 | - | 1 | Sep 13, 2021 | |
| SLNO Soleno Therapeutics | Initiates: Buy | n/a | $39.73 | - | 1 | Dec 23, 2019 |
Affimed
Jun 13, 2024
Maintains: Buy
Price Target: $15 → $25
Current: $5.16
Upside: +384.97%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $2.5
Current: $0.35
Upside: +611.04%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.81
Upside: +827.87%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.32
Upside: -
Evofem Biosciences
Dec 13, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.01
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.95
Upside: +956.19%
Alaunos Therapeutics
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.63
Upside: -
Bellerophon Therapeutics
Jun 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.06
Upside: -
NLS Pharmaceutics AG
Sep 6, 2022
Initiates: Buy
Price Target: $6
Current: $0.20
Upside: +2,900.00%
Vincerx Pharma
Sep 13, 2021
Initiates: Buy
Price Target: n/a
Current: $0.74
Upside: -
Soleno Therapeutics
Dec 23, 2019
Initiates: Buy
Price Target: n/a
Current: $39.73
Upside: -